Lota S. Zoth - 13 May 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role: Director
Signature: /s/ Lota Zoth
Issuer symbol: INO
Transactions as of: 13 May 2022
Net transactions value: -$7,128
Form type: 4
Filing time: 17 May 2022, 16:28:06 UTC
Previous filing: 09 May 2022
Next filing: 18 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INO	Common Stock	Options Exercise		+18,000	+72%		43,016	13 May 2022	Direct	F1
transaction	INO	Common Stock	Sale	$7,128	-3,600	-8.4%	$1.98^*	39,416	16 May 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-18,000	-100%	$0.000000^*	0	13 May 2022	Common Stock	18,000		Direct	F1
transaction	INO	Restricted Stock Unit	Award	$0	+19,000		$0.000000	19,000	16 May 2022	Common Stock	19,000		Direct	F3, F4
transaction	INO	Common Stock Options	Award	$0	+28,000		$0.000000	28,000	16 May 2022	Common Stock	28,000	$1.89	Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2022.
F2	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F3	Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 16, 2023.
F4	This grant was made pursuant to the issuer's non-employee director compensation policy.
F5	Options to vest 100% on May 16, 2023.